Asthma Clinical Trials in Ann Arbor, Michigan

4 studies are recruiting for asthma in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

    To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.

    Stage
    Phase 3
    Ages
    5 to 11
    Site
    Research Site, Ann Arbor, Michigan
    Locations
    147 in total
    Run by
    AstraZeneca
  2. Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

    The rationale of the roll-over study (ROSY) is to provide continuous access to study treatment for participants who have completed or exited a parent study and are deemed appropriate for continued benralizumab treatment, as judged by the Investigator, while monitoring long-term safety and tolerabil…

    Stage
    Phase 3
    Ages
    6 and older
    Site
    Research Site, Ann Arbor, Michigan
    Locations
    45 in total
    Run by
    AstraZeneca
  3. Asthma and Technology in Emerging African American Adults

    The purpose of the ATHENA Project is to test a mobile health intervention to help African American young adults better manage their asthma. The program has four components: 1) a web-based, mobile asthma program delivered to participants' mobile device, 2) meetings with an asthma nurse via video con…

    Stage
    Not phased
    Ages
    18 to 30
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    3 in total
    Run by
    University of Michigan
  4. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

    The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning o…

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    North Ingalls Building, Ann Arbor, Michigan
    Locations
    132 in total
    Run by
    Pfizer

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.